News
News releases on January 4, 2022, page 3
Every news release public companies put out on January 4, 2022 (UTC): 500 news releases, newest first. Open any release to read it.
Viridian Therapeutics Submits Investigational New Drug Application for VRDN-002 to the U.S. Food and Drug Administration
Viridian Therapeutics, Inc. · Jan 4, 2022
Vir Biotechnology to Present at 40th Annual J.P. Morgan Healthcare Conference
Vir Biotechnology, Inc. · Jan 4, 2022
Viant Announces Appointment of Senior Vice President, Business Development
Viant Technology Inc. · Jan 4, 2022
Vertex to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10
Vertex Pharmaceuticals Incorporated · Jan 4, 2022
Vericel to Present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022
Vericel Corporation · Jan 4, 2022
Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Vera Therapeutics, Inc. · Jan 4, 2022
Valley National Bancorp Receives Regulatory Approval for the Acquisition of Bank Leumi USA From the Federal Reserve Bank of New York and ...
Valley National Bancorp · Jan 4, 2022
UTStarcom Announces Progress in Cooperation with China Unicom Research Institute on Development of 5G Transport Network Solution
UTStarcom Holdings Corp · Jan 4, 2022
urban-gro, Inc. Announces January 2022 Conference Participation
urban-gro, Inc. · Jan 4, 2022
Universe Pharmaceuticals INC Announces Strategic Alliance with Jiangxi Province Institute of Materia Medica to Conduct Research on Tradit...
Universe Pharmaceuticals Inc · Jan 4, 2022
United to Hold Webcast of Fourth-Quarter and Full-Year 2021 Financial Results
United Airlines Holdings, Inc. · Jan 4, 2022
UEI Launches New and Sustainable Whole-Home Control Solutions at CES 2022
Universal Electronics Inc. · Jan 4, 2022
Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference
Twist Bioscience Corporation · Jan 4, 2022
Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer
Travere Therapeutics, Inc. · Jan 4, 2022
Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines
Tonix Pharmaceuticals Holding Corp. · Jan 4, 2022
Tonia O’Connor Appointed to Xperi Board of Directors
Adeia Inc. · Jan 4, 2022
TI advances driver assistance technology to more accurately monitor blind spots and efficiently navigate turns and corners to safely avoi...
Texas Instruments Incorporated · Jan 4, 2022
The Power of ONE – CORSAIR Launches New CORSAIR ONE i300 Powered by 12th Gen Intel® Core™ and DDR5
Corsair Gaming, Inc. · Jan 4, 2022
The Joint Chiropractic Opens at Luke Air Force Base, Bringing Chiropractic Care to the Military
The Joint Corp. · Jan 4, 2022
The Ensign Group Adds a Skilled Nursing Facility in Arizona
The Ensign Group, Inc. · Jan 4, 2022
The Beauty Health Company Announces Participation in the 2022 ICR Conference
SkinHealth Systems Inc. · Jan 4, 2022
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
TG Therapeutics, Inc. · Jan 4, 2022
Texas Instruments to webcast Q4 2021 and 2021 earnings conference call
Texas Instruments Incorporated · Jan 4, 2022
Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs
Tenax Therapeutics, Inc. · Jan 4, 2022
Tarsus Appoints Elizabeth Yeu, M.D., a Nationally Recognized Ophthalmologist and Eye Care Leader, to its Board of Directors
Tarsus Pharmaceuticals, Inc. · Jan 4, 2022
Sunrun Announces Appointment of Manjula Talreja to its Board of Directors
Sunrun Inc. · Jan 4, 2022
Stoke Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Stoke Therapeutics, Inc. · Jan 4, 2022
Steve Austenfeld Appointed Vice President, Investor Relations of the Honest Company
The Honest Company, Inc. · Jan 4, 2022
SS&C Announces Strategic Deal with O'Shares ETFs
SS&C Technologies Holdings, Inc. · Jan 4, 2022
Spero Therapeutics Announces Lifting of FDA Clinical Trial Hold on SPR720
Spero Therapeutics, Inc. · Jan 4, 2022
Solid Biosciences Reports Inducement Grant to New Senior Vice President, Human Resources
Solid Biosciences Inc. · Jan 4, 2022
Skyharbour Resources Appoints Dr. Andrew J. Ramcharan as Senior Vice President of Corporate Development
Skyharbour Resources Ltd. · Jan 4, 2022
Shiftall Introduces MaganeX, World’s First 5.2K High-Dynamic-Range Virtual-Reality Glasses at CES 2022 Incorporating Kopin’s 2.6K x 2.6K ...
Kopin Corporation · Jan 4, 2022
Shawn Carlson Joins 1st Security Bank as VP, Community & Business Banking Officer
FS Bancorp, Inc. · Jan 4, 2022
SGH Reports First Quarter Fiscal 2022 Financial Results
Penguin Solutions, Inc. · Jan 4, 2022
Senseonics Announces Business Updates
Senseonics Holdings, Inc. · Jan 4, 2022
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
SciSparc Ltd. · Jan 4, 2022
Scholar Rock to Present at the 40th Annual J.P. Morgan Healthcare Conference
Scholar Rock Holding Corporation · Jan 4, 2022
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Savara, Inc. · Jan 4, 2022
Sangamo Therapeutics Announces Participation at H.C. Wainwright BIOCONNECT Virtual Conference
Sangamo Therapeutics, Inc. · Jan 4, 2022
Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference
Sana Biotechnology, Inc. · Jan 4, 2022
SAIC Selected by U.S. General Services Administration for ASTRO Family of Contracts to Provide a Broad Array of IT Support Services
Science Applications International Corporation · Jan 4, 2022
RxSight, Inc. Appoints Dr. Tamara R. Fountain, M.D. and Shweta Singh Maniar to its Board of Directors
RxSight, Inc. · Jan 4, 2022
Roku Chief Financial Officer to Present at Citi’s 2022 AppsEconomy Virtual Conference
Roku, Inc. · Jan 4, 2022
Rockridge Resources Announces Strategic Appointment of Dr. Andrew J. Ramcharan as Senior Vice President of Corporate Development
Trident Resources Corp. · Jan 4, 2022
Rocket Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
Rocket Pharmaceuticals, Inc. · Jan 4, 2022
Rick Astley & Frito-Lay® team up to flip traditional New year's resolutions upside down with "New Year, New You" campaign
PepsiCo, Inc. · Jan 4, 2022
Revolution Medicines to Provide R&D Update, Including Expansion of Development-Stage RAS(ON) Inhibitor Pipeline, During Presentation at 4...
Revolution Medicines, Inc. · Jan 4, 2022
ReTo Eco-Solutions, Inc. Enters into an Equity Acquisition Agreement to Acquire Solution and Product Provider of Internet of Things
ReTo Eco-Solutions, Inc. · Jan 4, 2022
Replimune to Present at the 40th Annual J.P. Morgan Healthcare Conference
Replimune Group, Inc. · Jan 4, 2022
Rent-A-Center Opens Store in Neosho, MO
Upbound Group, Inc. · Jan 4, 2022
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In...
Relay Therapeutics, Inc. · Jan 4, 2022
Rekor Systems to Pilot Roadway Analytics at Philadelphia Navy Yard
Rekor Systems, Inc. · Jan 4, 2022
Regency Centers Invites You to Join Its Fourth Quarter 2021 Earnings Conference Call
Regency Centers Corporation · Jan 4, 2022
Red Pine Exploration Updates on its December 31 Warrant Exercising
RPX Gold · Jan 4, 2022
RCI to Participate in 24th Annual ICR Conference on Jan. 10-12, 2022
RCI Hospitality Holdings, Inc. · Jan 4, 2022
Radware Schedules Conference Call for Its Fourth Quarter and Full Year 2021 Earnings
Radware Ltd. · Jan 4, 2022
Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference
QuidelOrtho Corporation · Jan 4, 2022
Quantum-Si Signs Lease for New Headquarters in New Haven
Quantum-Si Incorporated · Jan 4, 2022
Quantum Computing Inc. Appoints Michael C. Turmelle to its Board of Directors
Quantum Computing Inc. · Jan 4, 2022
Pyxis Tankers Announces Sale of Two Small Tankers
Pyxis Tankers Inc. · Jan 4, 2022
Pure Cycle Corporation Announces Three Months Ended November 30, 2021 Earnings Call
Pure Cycle Corporation · Jan 4, 2022
Protara Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
Protara Therapeutics, Inc. · Jan 4, 2022
ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen
ProQR Therapeutics N.V. · Jan 4, 2022
PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors
PROCEPT BioRobotics Corporation · Jan 4, 2022
Privia Health to Participate in 40th Annual J.P. Morgan Healthcare Conference
Privia Health Group, Inc. · Jan 4, 2022
Presidio Property Trust Announces Special Warrant Dividend
Presidio Property Trust, Inc. · Jan 4, 2022
Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
Prelude Therapeutics Incorporated · Jan 4, 2022
PolyPid Appoints UCSF Brain Tumor Center Director Mitchel S. Berger, M.D., to Oncology Advisory Board
PolyPid Ltd. · Jan 4, 2022
Plus Therapeutics Announces Two Significant Milestones Toward cGMP Manufacture of its Lead Investigational Radiotherapeutic
Plus Therapeutics, Inc. · Jan 4, 2022
PLBY Group to Participate in Upcoming Investor Conferences
Playboy, Inc. · Jan 4, 2022
PharmaCyte Biotech Study Proves Capsule Material Is Not Toxic For Encapsulated Cells
PharmaCyte Biotech, Inc. · Jan 4, 2022
Pegasystems Appoints Katherine Parente as Chief People Officer
Pegasystems Inc. · Jan 4, 2022
Pegasus Resources Inc. Extends High-grade Polymetallic Mineralized System to Over 900 Meters Strike Length at the Gold Mountain Property
Pegasus Resources Inc · Jan 4, 2022
Palo Alto Networks Appoints Helmut Reisinger to Leadership Team
Palo Alto Networks, Inc. · Jan 4, 2022
PACCAR Exhibits Innovative Electric, Connected and Autonomous Trucks at CES 2022
PACCAR Inc. · Jan 4, 2022
PacBio to Present at Upcoming Investor Conference
Pacific Biosciences of California, Inc. · Jan 4, 2022
P3 Health Partners Expands to California, Closes Acquisition of Medcore HP and Omni IPA Medical Group, Inc.
P3 Health Partners Inc. · Jan 4, 2022
Outback Goldfields to List on the TSX Venture Exchange
Valkea Resources Corp · Jan 4, 2022
Origin Agritech Announces Collaboration with BaoDao Feed Ltd. To Commercialize Nutrition Enhanced Corn
Origin Agritech Limited · Jan 4, 2022
ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
Oric Pharmaceuticals, Inc. · Jan 4, 2022
Opus One Resources Announces Closing of a Flow-Through Private Placement Financing
Opus One Gold Corporation · Jan 4, 2022
One World Lithium Announces Drill Hole Sample Results from Salar Del Diablo Project
One World Lithium, Inc. · Jan 4, 2022
OneWater Marine Inc. Completes Floorplan Financing Expansion
OneWater Marine Inc. · Jan 4, 2022
OneSpan Appoints Technology Industry Leader Tom Aurelio as Chief People Officer
OneSpan Inc. · Jan 4, 2022
Omnicell Acquires MarkeTouch Media
Omnicell, Inc. · Jan 4, 2022
Omai Gold Mines Announces Initial Mineral Resource Estimate: 703,300 Gold Ounces Indicated and 940,000 Ounces Inferred
Omai Gold Mines Corp. · Jan 4, 2022
Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference
Olema Pharmaceuticals, Inc. · Jan 4, 2022
Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Ocular Therapeutix, Inc. · Jan 4, 2022
NXP Ramps Flagship 4D Imaging Radar Chip to Production, Adds New Product Tailored for Fast-Growing L2+ Market
NXP Semiconductors N.V. · Jan 4, 2022
NXP Advances IoT Connectivity with Industry’s First Secure Tri-Radio Device
NXP Semiconductors N.V. · Jan 4, 2022
Nuvalent to Present at the 40th Annual J.P. Morgan Healthcare Conference
Nuvalent, Inc. · Jan 4, 2022
Nutanix Announces Elimination of Dual-Class Stock Structure
Nutanix, Inc. · Jan 4, 2022
Novocure to Participate in the 40th Annual J.P. Morgan Healthcare Conference
NovoCure Limited · Jan 4, 2022
Novavax to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Novavax, Inc. · Jan 4, 2022
Noodles & Company Takes Menu Innovation to the Next Level with LEANguini - a Fresh Pasta with Lower Carbs and Higher Protein than Traditi...
Noodles & Company · Jan 4, 2022
New Mobileye EyeQ Ultra Will Enable Consumer AVs
Intel Corporation · Jan 4, 2022
New In-Circuit Emulator (ICE) Boosts Productivity with Feature-Rich Programming and Debugging
Microchip Technology Incorporated · Jan 4, 2022
NeuroSense Therapeutics, Ltd. Announces the Presentation of Phase IIa Study Results at Four International Conferences
NeuroSense Therapeutics Ltd. · Jan 4, 2022
NETSOL Assures Protection of Customer Data with SOC 2 Type 1 Compliance
NETSOL Technologies Inc. · Jan 4, 2022